Dartmouth Health
Physician Scientist/Clinician Investigator, Cancer Signaling, Genomics and Networks, Dartmouth Cancer Center
The role involves pursuing careers in cancer research as a physician-scientist or clinician-investigator/clinical trialist across basic, translational, clinical, or population-based cancer research. Members of the Cancer Signaling, Genomics and Networks (SGN) research program apply innovative genetic, molecular, and computational biology approaches to cancer research, collaborating across laboratory and clinical disciplines to accelerate discoveries and clinical translation.
Key Responsibilities
- • Pursue careers in cancer research including basic, translational, clinical or population-based approaches.
- • Align research with one or more of the SGN program themes: Cancer Cell Biology and Biochemistry, Cancer Genomics and Computational Oncology, Translational Oncology.
- • Collaborate with laboratory-based scientists, pharmacologists, and oncologists to accelerate discoveries in cancer biology and promote clinical translation of laboratory findings.
- • Report to the appropriate Section Chief and Department Chair.
Required
- • Hold an M.D. or M.D./Ph.D degree (or equivalent).
- • Completed relevant clinical and postdoctoral research experience.
- • Board certified or board eligible in their medical or surgical specialty.
- • Eligible for medical licensure in both New Hampshire and Vermont.
- • Must obtain New Hampshire Medical license.
Benefits & Perks
- • Paid vacation, holiday and sick days.
- • Competitive CME allowance and dedicated CME time.
- • Medical/dental/vision coverage.
- • Employer-funded retirement plan.
- • Generous relocation bonus.
The Dartmouth Cancer Center (DCC), Geisel School of Medicine and Dartmouth Health are seeking to jointly recruit junior faculty dedicated to pursuing careers in cancer research. Physician-scientists and clinician-investigators/clinical trialists from all clinical specialties who are pursuing basic, translational, clinical or population-based cancer research are encouraged to apply. Successful applicants will be appointed as Assistant or Associate Professors in the appropriate department at Dartmouth and become full DCC members. Protected time for research and generous start-up packages will be provided.
Members of DCC’s Cancer Signaling, Genomics and Networks (SGN) research program apply innovative approaches in genetic, molecular, and computational biology to investigate essential questions in cancer research. Current SGN members align with one or more of three scientifically organized themes 1) Cancer Cell Biology and Biochemistry, 2) Cancer Genomics and Computational Oncology, 3) and Translational Oncology. SGN brings together laboratory-based scientists, pharmacologists, and surgical, medical and radiation oncologists to accelerate discoveries in cancer biology, promote clinical translation of laboratory findings, and provide clinical perspectives on basic and translational studies.
As one of only 57 NCI-Designated Comprehensive Cancer Centers and the only one north of Boston and east of Buffalo, DCC benefits from deep integration across the entirety of both Dartmouth and Dartmouth Health. With the successful renewal of its NCI designation in 2024, DCC is now poised to enter its second half-century of continuous NCI designation. In addition to a robust clinical trials enterprise, DCC hosts four vibrant NCI-funded Research Programs Immunology and Cancer Immunotherapy (ICI), Cancer Signaling, Genomes and Networks (SGN), Translational Engineering in Cancer (TEC) and Cancer Population Sciences (CPS).
Reporting to their appropriate Section Chief and Department Chair, successful applicants will be board-eligible or board-certified in their cancer-related clinical specialty and eligible for medical licensure in both New Hampshire and Vermont. Dartmouth Health offers an outstanding benefits package including, but not limited to paid vacation, holiday and sick days, competitive CME allowance and dedicated CME time, medical/dental/vision coverage, employer-funded retirement plan, and a generous relocation bonus.
At DCC, we believe that the diversity of our patients, people, and community shows a strength we support and celebrate. We are committed to creating a welcoming and inclusive environment for everyone to thrive, honoring all within our organization and the communities we serve. Our belief is simple and actionable Dartmouth Health is better when we embrace each other with open hearts and minds, confront our biases, and take a stand for equity and inclusion.
Interested applicants may also send their CV to Dartmouth.Cancer.Center.Jobs@Dartmouth.edu. This position will remain posted until filled.
Members of DCC’s Cancer Signaling, Genomics and Networks (SGN) research program apply innovative approaches in genetic, molecular, and computational biology to investigate essential questions in cancer research. Current SGN members align with one or more of three scientifically organized themes 1) Cancer Cell Biology and Biochemistry, 2) Cancer Genomics and Computational Oncology, 3) and Translational Oncology. SGN brings together laboratory-based scientists, pharmacologists, and surgical, medical and radiation oncologists to accelerate discoveries in cancer biology, promote clinical translation of laboratory findings, and provide clinical perspectives on basic and translational studies.
As one of only 57 NCI-Designated Comprehensive Cancer Centers and the only one north of Boston and east of Buffalo, DCC benefits from deep integration across the entirety of both Dartmouth and Dartmouth Health. With the successful renewal of its NCI designation in 2024, DCC is now poised to enter its second half-century of continuous NCI designation. In addition to a robust clinical trials enterprise, DCC hosts four vibrant NCI-funded Research Programs Immunology and Cancer Immunotherapy (ICI), Cancer Signaling, Genomes and Networks (SGN), Translational Engineering in Cancer (TEC) and Cancer Population Sciences (CPS).
Reporting to their appropriate Section Chief and Department Chair, successful applicants will be board-eligible or board-certified in their cancer-related clinical specialty and eligible for medical licensure in both New Hampshire and Vermont. Dartmouth Health offers an outstanding benefits package including, but not limited to paid vacation, holiday and sick days, competitive CME allowance and dedicated CME time, medical/dental/vision coverage, employer-funded retirement plan, and a generous relocation bonus.
At DCC, we believe that the diversity of our patients, people, and community shows a strength we support and celebrate. We are committed to creating a welcoming and inclusive environment for everyone to thrive, honoring all within our organization and the communities we serve. Our belief is simple and actionable Dartmouth Health is better when we embrace each other with open hearts and minds, confront our biases, and take a stand for equity and inclusion.
Interested applicants may also send their CV to Dartmouth.Cancer.Center.Jobs@Dartmouth.edu. This position will remain posted until filled.
- Candidates should hold an M.D. or M.D./Ph.D degree (or equivalent), have completed relevant clinical and postdoctoral research experience and be board certified or board eligible in their medical or surgical specialty.
- Must obtain New Hampshire Medical license
Keep track of your job search
Save personal notes for each job to track your thoughts, application status, and follow-ups.
Try for freeUpload your resume
Sign up to upload your resume and get AI-powered customization for job applications.
Sign up freePractice your interview
Get AI-powered mock interviews tailored to this Physician Scientist/Clinician Investigator, Cancer Signaling, Genomics and Networks, Dartmouth Cancer Center role. Upload your resume and practice with real-time voice feedback.
Sign up to practice